S. He et al., Potent inhibition of serine proteases by heterocyclic sulfide derivatives of 1,2,5-thiadiazolidin-3-one 1,1 dioxide, BIO MED CH, 8(7), 2000, pp. 1713-1717
The existence of subtle differences in the S-n' subsites of closely-related
(chymo)trypsin-like serine proteases, and the fact that the 1,2,5-thiadiaz
olidin-3-one 1,1 dioxide scaffold docks to the active site of (chymo)trypsi
n-like enzymes in a substrate-like fashion, suggested that the introduction
of recognition elements that can potentially interact with the S-n' subsit
es of these proteases might provide an effective means for optimizing enzym
e potency and selectivity. Accordingly, a series of heterocyclic sulfide de
rivatives based on the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold (I)
was synthesized and the inhibitory activity and selectivity of these compou
nds toward human leukocyte elastase (HLE), proteinase 3 (PR 3) and cathepsi
n G (Cat G) were then determined. Compounds with P-1 = isobutyl were found
to be potent, time-dependent inhibitors of HLE and, to a lesser extent PR 3
, while those with P-1 = benzyl inactivated Cat G rapidly and irreversibly.
This study has demonstrated that 1,2,5-thiadiazolidin-3-one 1,1 dioxide-ba
sed heterocyclic sulfides are effective inhibitors of (chymo)trypsin-like s
erine proteases. (C) 2000 Elsevier Science Ltd. All rights reserved.